Central Shunt Procedures for Complex Congenital Heart Diseases

The study was designed to analyze the results of central shunt procedure using Gore‐Tex grafts for treatment of patients with complex congenital heart diseases.

[1]  F. Macartney,et al.  Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. , 1981, The Journal of thoracic and cardiovascular surgery.

[2]  J. Galati,et al.  Side-to-side aorto-GoreTex central shunt warrants central shunt patency and pulmonary arteries growth. , 2011, The Annals of thoracic surgery.

[3]  H. Taussig,et al.  The Surgical Treatment of Malformations of the Heart: In Which There Is Pulmonary Stenosis or Pulmonary Atresia , 1945 .

[4]  W. Wells,et al.  Does the site of insertion of a systemic-pulmonary shunt influence growth of the pulmonary arteries? , 2005, The Annals of thoracic surgery.

[5]  K. Ehlers,et al.  Early Results and Late Developments of the Waterston Anastomosis , 1974, Circulation.

[6]  Bradford J. Kim,et al.  Two thousand Blalock-Taussig shunts: a six-decade experience. , 2007, The Annals of thoracic surgery.

[7]  L. Sauvage,et al.  Autologous pericardium for mitral leaflet advancement. Findings in the human after 56 months. , 1966, Journal of Thoracic and Cardiovascular Surgery.

[8]  J E Mayer,et al.  Sternotomy approach for the modified Blalock-Taussig shunt. , 1995, Circulation.

[9]  F. Crawford,et al.  The Blalock-Taussig shunt in infants: standard versus modified. , 1987, The Annals of thoracic surgery.

[10]  R. B. Cole,et al.  Long‐term Results of Aortopulmonary Anastomosis for Tetralogy of Fallot: Morbidity and Mortality, 1946–1969 , 1971, Circulation.

[11]  S. Choudhary,et al.  Modified blalock-taussig shunt in neonates. , 2009, Heart, lung & circulation.

[12]  W. S. Ring,et al.  Central aorta-pulmonary artery shunts in neonates with complex cyanotic congenital heart disease. , 1987, The Journal of thoracic and cardiovascular surgery.

[13]  A. Wessel,et al.  Reduced frequency of occlusion of aorto-pulmonary shunts in infants receiving Aspirin , 1999, Cardiology in the Young.

[14]  P. Kapoor,et al.  Central pulmonary artery histopathology in patients with cyanotic congenital heart diseases. , 2009, The Annals of thoracic surgery.

[15]  R. Califf,et al.  Clinical Outcomes of Palliative Surgery Including a Systemic-to-Pulmonary Artery Shunt in Infants With Cyanotic Congenital Heart Disease: Does Aspirin Make a Difference? , 2007, Circulation.

[16]  K. S. Murthy,et al.  Sternotomy Approach for Modified Blalock-Taussig Shunt: Is it a Safe Option? , 2010, Asian cardiovascular & thoracic annals.

[17]  H. B. Shumacker,et al.  Ascending aorticpulmonary artery shunts in cyanotic heart disease. , 1962, Surgery.

[18]  J J Amato,et al.  Systemic-pulmonary polytetrafluoroethylene shunts in palliative operations for congenital heart disease. Revival of the central shunt. , 1988, The Journal of thoracic and cardiovascular surgery.